Pinnacle Wealth Planning Services Inc. Buys 274 Shares of HCA Healthcare, Inc. $HCA

Pinnacle Wealth Planning Services Inc. boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 38.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 979 shares of the company’s stock after purchasing an additional 274 shares during the period. Pinnacle Wealth Planning Services Inc.’s holdings in HCA Healthcare were worth $375,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in HCA. Price T Rowe Associates Inc. MD raised its stake in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. raised its position in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after purchasing an additional 587,036 shares during the period. Nuveen LLC bought a new position in HCA Healthcare in the 1st quarter worth approximately $569,217,000. Pacer Advisors Inc. lifted its position in shares of HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after acquiring an additional 1,329,618 shares in the last quarter. Finally, Nordea Investment Management AB grew its position in shares of HCA Healthcare by 6.8% in the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after purchasing an additional 59,163 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on HCA shares. Zacks Research raised HCA Healthcare from a “hold” rating to a “strong-buy” rating in a report on Wednesday, October 29th. Jefferies Financial Group upped their target price on shares of HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a report on Tuesday, October 28th. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday. Royal Bank Of Canada lifted their price objective on HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. Finally, Wall Street Zen raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Stock Up 0.3%

Shares of HCA stock opened at $478.64 on Wednesday. The firm has a market cap of $109.22 billion, a P/E ratio of 18.50, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. The business has a 50-day moving average price of $436.04 and a two-hundred day moving average price of $398.67. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $480.00.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same period last year, the firm posted $4.90 EPS. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.